VOLPE, Gisella
 Distribuzione geografica
Continente #
NA - Nord America 865
EU - Europa 356
AS - Asia 253
AF - Africa 1
SA - Sud America 1
Totale 1.476
Nazione #
US - Stati Uniti d'America 854
CN - Cina 118
SG - Singapore 62
IT - Italia 58
IE - Irlanda 55
SE - Svezia 41
FI - Finlandia 40
FR - Francia 36
UA - Ucraina 33
DE - Germania 28
KR - Corea 22
PL - Polonia 18
AT - Austria 17
GB - Regno Unito 15
JP - Giappone 15
VN - Vietnam 13
BE - Belgio 9
CA - Canada 9
HK - Hong Kong 9
ID - Indonesia 5
IN - India 4
IQ - Iraq 3
MX - Messico 2
TR - Turchia 2
AR - Argentina 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
LV - Lettonia 1
NO - Norvegia 1
RU - Federazione Russa 1
SN - Senegal 1
Totale 1.476
Città #
Chandler 138
Beijing 84
Dublin 55
Fairfield 54
Singapore 49
Ann Arbor 43
Ashburn 41
Santa Clara 37
Fremont 31
Houston 29
Woodbridge 29
Villeurbanne 27
Wilmington 27
Cambridge 26
Seattle 26
Nyköping 25
Torino 21
Dearborn 20
Jacksonville 20
Pisa 18
Warsaw 18
Medford 17
Vienna 17
Princeton 16
Dong Ket 13
Columbus 12
Falls Church 12
Brussels 9
Hong Kong 9
Düsseldorf 8
Milan 8
Boardman 6
Helsinki 6
Boston 5
Jakarta 5
Nanjing 5
Shanghai 5
Redmond 4
Toronto 4
Des Moines 3
Hefei 3
Lachine 3
Los Angeles 3
Phoenix 3
Washington 3
Zhengzhou 3
Arbil 2
Honolulu 2
Jinan 2
Kunming 2
Munich 2
New York 2
Ottawa 2
Redwood City 2
San Diego 2
San Jose 2
Tokyo 2
Upper Marlboro 2
Verona 2
Xian 2
Akron 1
Antalya 1
Auburn Hills 1
Baoding 1
Bengaluru 1
Bogen 1
Borgo San Dalmazzo 1
Boydton 1
Brno 1
Changchun 1
Chongqing 1
Council Bluffs 1
Genova 1
Guangzhou 1
Hangzhou 1
Hermosillo 1
Indianapolis 1
La Jolla 1
Meerut 1
Modena 1
Mountain View 1
Mumbai 1
Norwalk 1
Philadelphia 1
Phoenixville 1
Porth 1
Riga 1
Rouen 1
Saint-sulpice-et-cameyrac 1
San Francisco 1
San Mateo 1
San Nicolas 1
Seoul 1
Shaoxing 1
Shenyang 1
Silver Spring 1
Stavanger 1
Suzhou 1
Takamatsu 1
Tallinn 1
Totale 1.068
Nome #
Analysis of microsatellite instability in chronic lymphoproliferative disorders 195
New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia 176
The Wilms' tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapy 171
NEW ALTERNATIVE PROTEIN Bcr/Abl-OOF SHOWS ONCOGENIC ACTIVITY BY ACTIVATION OF RAC AND COOPERATION WITH Bcr/Abl IN CHRONIC MYELOID LEUKEMIA. 124
Specific Monoclonal Antibody Against Bcr/Abl Out-of-Frame Alternative Proteins as Diagnostic Tool in Chronic Myelogenous Leukemia Patients 122
Management of pulmonary arterial hypertension associated to thalassemia: when pulmonary endarterectomy is the best therapeutical option? A case report. 109
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches 104
A new oncogenic role of BCR-ABL/OOF in chronic myeloid leukemia pathogenesis 96
Out of frame peptides from BCR/ABL alternative splicing are immunogenic in HLA A2.1 transgenic mice 71
Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients 67
Immunologic evaluation of peptides derived from BCR/ABL-out-of-frame fusion protein in HLA A2.1 transgenic mice 63
Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia 62
New perspectives for molecular targeted therapy in human leukemias 61
Characterization of a monoclonal antibody specific for novel Bcr/Abl out-of-frame fusion proteins. 56
Imatinib resistance in CML 49
Totale 1.526
Categoria #
all - tutte 4.493
article - articoli 0
book - libri 0
conference - conferenze 663
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.156


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020149 0 0 0 0 15 28 28 14 18 27 9 10
2020/2021150 12 15 17 5 20 3 11 7 13 10 13 24
2021/2022192 5 7 3 13 11 8 10 12 4 17 67 35
2022/2023320 27 40 7 43 25 79 15 19 35 6 18 6
2023/202489 15 23 6 3 3 7 2 5 0 4 7 14
2024/2025139 5 7 18 28 81 0 0 0 0 0 0 0
Totale 1.526